Pulmonary Nocardia Farcinica Infection In A Patient With Scleroderma-Associated Interstitial Lung Disease

被引：0
|
作者：
Mehta, S. [1 ]
Cowan, B. [1 ]
Flynn, A. [1 ]
机构：
[1] Northern Navajo Med Ctr, Shiprock, NM USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2015年 / 191卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1834
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Update on scleroderma-associated interstitial lung disease
    Fan, Ming-Hui
    Feghali-Bostwick, Carol A.
    Silver, Richard M.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (06) : 630 - 636
  • [2] Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease
    Gerbino, Anthony J.
    Goss, Christopher H.
    Molitor, Jernj A.
    CHEST, 2008, 133 (02) : 455 - 460
  • [3] Effect Of Mycophenolate Mofetil On Scleroderma-Associated Interstitial Lung Disease
    Baqir, M.
    Makol, A.
    Osborn, T. G.
    Bartholmai, B.
    Ryu, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [4] A New Era in the Treatment of Scleroderma-associated Interstitial Lung Disease?
    Launay, David
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (09) : 1619 - 1621
  • [5] SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD)
    Silver, R.
    RHEUMATOLOGY, 2012, 51 : I12 - I12
  • [6] Nocardia farcinica as the Causative Agent of a Brain Abscess in a Patient with Interstitial Lung Disease
    Scharfen, J., Jr.
    Moravkova, M.
    Buncek, M.
    Hobza, V
    Plisek, S.
    Urbaskova, P.
    Sedlacek, I
    Zemlickova, H.
    Starkova, H.
    Paterova, P.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2010, 59 (01): : 13 - 20
  • [7] Safety and Tolerability of Thrombin Inhibition in Scleroderma-Associated Interstitial Lung Disease
    Silver, R. M.
    Wilson, D. A.
    Akter, T.
    Atanelishvili, I.
    Huggins, J. T.
    Kajdasz, K.
    Highland, K. B.
    Nietert, P. J.
    Bogatkevich, G. S.
    ACR OPEN RHEUMATOLOGY, 2019, 1 (07) : 403 - 411
  • [8] Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab
    McGonagle, D.
    Tan, A. L.
    Madden, J.
    Rawstron, A. C.
    Rehman, A.
    Emery, P.
    Thomas, S.
    RHEUMATOLOGY, 2008, 47 (04) : 552 - 553
  • [9] Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease
    Zamora, Ana C.
    Wolters, Paul J.
    Collard, Harold R.
    Connolly, M. Kari
    Elicker, Brett M.
    Webb, W. Richard
    King, Talmadge E., Jr.
    Golden, Jeffrey A.
    RESPIRATORY MEDICINE, 2008, 102 (01) : 150 - 155
  • [10] Clinical features of scleroderma sine scleroderma-associated progressive interstitial lung disease.
    Fischer, A
    Cosgrove, GP
    Collard, HR
    Feghali-Bostwick, CA
    Loucks, J
    West, SG
    Meehan, RT
    Brown, KK
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S589 - S589
12345